Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Abacus Global Management Refutes False And Misleading Short Seller Report Alleging Overreliance On Single Life Expectancy Provider Lapetus Solutions And Inflated Balance Sheet Valuation

Author: Benzinga Newsdesk | June 10, 2025 07:57am

Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a leader in the alternative asset management space, today provided the following response to last week's false and misleading short attack.

Our shareholders have been subjected to a false and uninformed short attack. The short seller's report published on June 4, 2025 makes two key allegations: first, that Abacus relies too heavily on a single life expectancy provider (Lapetus Solutions), and second, that this reliance has significantly inflated our balance sheet valuation. Both are incorrect.

Posted In: ABL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist